Manila Times Business
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution
LOUISVILLE, Ky, June 04, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Shorla Oncology for JYLAMVO® (methotrexate), indicated for the treatment of adults and pediatric patients with acute lymphoblastic leukemia (ALL), mycosis fungoides, adults with rheumatoid arthritis, adults with relapsed or refractory non-Hodgkin lymphoma, pediatric patients with polyarticular juvenile idiopathic arthritis, and adults with se
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Trusted by the Majority of Top 30 U.S. Accounting Firms, Caseware Launches Verity Agentic Pioneer Program
Just now
IperionX Titan DFS Confirms High-Return U.S. Rare Earths and Critical Minerals Project
Just now
Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
Just now
Innovation Labs by Identity Digital Submits DNS-Anchored Durable Identity Proposal for AI Agents to the IETF
Just now